Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
In vivo screen identifies LXR agonism potentiates sorafen... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
In vivo screen identifies LXR agonism potentiates sorafenib killing of hepatocellular carcinoma
0
Authors
Morgan Preziosi
9 more
Morgan Preziosi
•
Adam Zahm
7 more
•
Kirk Wangensteen
Published
June 13, 2019
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Biochemistry
Medicine
Cancer Oncology
Surgery
Show all topics
DOI
10.1101/668350
License
cc-no
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Biochemistry
Medicine
Cancer Oncology
Surgery
Show all topics
DOI
10.1101/668350
License
cc-no
